Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 11,955 | 13,258 | 15,931 | 14,445 | 11,954 |
| Cost of Goods | 9,108 | 11,730 | 16,418 | 12,661 | 9,300 |
| Gross Profit | 2,847 | 1,528 | -487 | 1,784 | 2,654 |
| Operating Expenses | 7,175 | 9,340 | 11,673 | 13,168 | 9,440 |
| Operating Income | -4,220 | -7,082 | -11,742 | -10,723 | -6,486 |
| Interest Expense | 35 | 39 | 0 | 0 | 0 |
| Other Income | 91 | -23 | -40 | -126 | -124 |
| Pre-tax Income | -4,164 | -7,144 | -11,782 | -10,849 | -6,610 |
| Income Tax | 61 | 68 | -60 | 90 | 76 |
| Net Income Continuous | -4,225 | -7,212 | -11,722 | -10,939 | -6,686 |
| Net Income | $-4,225 | $-7,212 | $-11,722 | $-10,939 | $-6,686 |
| EPS Basic Total Ops | -39.57 | -68.35 | -64.75 | -235.61 | -181.65 |
| EPS Basic Continuous Ops | -39.41 | -67.87 | -66.39 | -235.17 | -180.80 |
| EPS Diluted Total Ops | -39.57 | -68.35 | -64.75 | -235.61 | -181.65 |
| EPS Diluted Continuous Ops | -39.41 | -67.87 | -66.39 | -235.17 | -180.80 |
| EBITDA(a) | $-4,225 | $-7,091 | $-11,244 | $-10,137 | $-5,995 |